Default company panoramic image

HepQuant, LLC

HepQuant’s unique technology provides accurate, safe, and cost-effective liver function testing to enable chronic liver disease research and drug development.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Greenwood Village, CO, US
  • Currency USD
  • Founded June 2007
  • Employees 0
  • Website

Company Summary

HepQuant is an early-stage medical diagnostics company with unique, patented and patent-pending noninvasive liver tests: HepQuant-SHUNT, -FLOW, and -STAT. Revenue is based on contracts for test performance and lab analysis. In Phase 1 of our business plan, we will focus on expanding accounts with pharma partners and liver research centers. In Phase 2, we will directly market tests to care providers, insurers, and third-party payors.


  • Default avatar
    Gregory T. Everson, MD, FACP
    Founder, Chief Medical Officer

  • Default avatar
    Randall Dietrich, MBA, CPA
    Interim CEO, Managing Member

  • Default avatar
    Steve Helmke, Ph. D
    Consulting Technical Manager, Laboratory Affairs

  • Default avatar
    Jennifer Payne
    Consulting Financial Manager

  • Default avatar
    Lisa Goggin, MBA, CPCU
    Managing Director of Business Operations

  • Default avatar
    Tom Kennedy, MBA
    Managing Director, Investor Relations & Marketing

  • Default avatar
    Bradley Everson
    Managing Director, Sales & Business Development


  • Default avatar
    Daniel Wobbekind, Cooley, LLLP
    Default avatar
    Currently unaudited.

Previous Investors

  • Default avatar
    Confidential. Available Upon Request